TORONTO, ON--(Marketwired - June 16, 2015) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) today announced that it has signed an Option Agreement with Platform Imaging, LLC to acquire the exclusive rights to integrate camera control software into the SPORT™ Surgical System. This sophisticated tool-tracking software will enable automation of the pan and tilt functions of the camera module to provide surgeons with a view of the surgical field without the need to manually position and reposition the camera.

Dennis Fowler, Executive Vice President, Clinical and Regulatory Affairs of Titan Medical Inc., commented, "We are very pleased to acquire this technology. The software will manage the cameras to maintain an ideal view of the surgical site, thus keeping the surgeon's attention on the actual procedure and not on repositioning the cameras. It will shorten the length of surgical procedures and reduce surgeons' cognitive load."

"We are excited to add this functionality to our SPORT Surgical System. We believe it will allow the surgeon to focus on the surgical procedure and contribute to our goals of increasing a hospital's return on investment clinically, financially, and operationally," said John Hargrove, Chairman and Chief Executive Officer of Titan Medical Inc. "This is the most recent example of Titan pursuing digital technology to enhance the surgeon's ability to deliver optimal surgical treatment."

Frank DeBernardis, CEO of Platform Imaging, stated, "We are thrilled that Titan will integrate this enabling technology into its SPORT Surgical System. Optimal imaging is critical for surgeons and their patients, and this technology will revolutionize the way surgeons visualize the surgical field."

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's Single Port Orifice Robotic Technology, SPORT™ Surgical System, currently under development, is comprised of a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT™ Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under-serviced. It is also being designed to allow surgeons to perform procedures within small- to medium-size surgical spaces for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website at

About Platform Imaging, LLC

Platform Imaging, LLC, is a developmental stage company focused on improving imaging for minimally invasive surgery. The company is developing single use, automated, insertable camera systems for surgery and other applications. The company uses proprietary tracking software to enable automation of image management in applications that require camera navigation.

Forward-Looking Statements

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors " section of the Company's Annual Information Form dated March 31, 2015 (which may be viewed at Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.

Contact Information:

Titan Medical Inc.
John Hargrove
Chairman & Chief Executive Officer
(416) 548-7522 (ext. 151)